Abbott Laboratories (ABT) Income from Discontinued Operations (2014 - 2018)

Abbott Laboratories has reported Income from Discontinued Operations for 5 years, with the latest figure at 9000000.0 in Q1 2018.

• Quarterly Income from Discontinued Operations fell 72.73% year-over-year to 9000000.0 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was 100000000.0 (down 9.09% YoY) and the FY2018 annual result came in at 34000000.0, down 72.58% from the prior year.
• Income from Discontinued Operations eased to 9000000.0 in Q1 2018 per ABT's latest filing, from 36000000.0 in the prior quarter.
• Over five years, Income from Discontinued Operations peaked at 270000000.0 in Q4 2014 and troughed at 32000000.0 in Q3 2015.
• A 5-year average of 63588235.29 and a median of 33000000.0 in 2016 frame the typical range for Income from Discontinued Operations.
• The sharpest annual moves came in 2015 and 2016: Income from Discontinued Operations sank 132.0% in 2015, then surged 1700.0% in 2016.
• Over 5 years, Income from Discontinued Operations stood at 270000000.0 in 2014, then plunged by 73.33% to 72000000.0 in 2015, then tumbled by 54.17% to 33000000.0 in 2016, then increased by 9.09% to 36000000.0 in 2017, then slumped by 75.0% to 9000000.0 in 2018.
• According to Business Quant data, Income from Discontinued Operations over the past three periods registered 9000000.0, 36000000.0, and 42000000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.